Media headlines about Canopy Growth (NYSE:CGC) have been trending somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Canopy Growth earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned news articles about the marijuana producer an impact score of 46.6164611063396 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

Shares of CGC opened at $51.53 on Monday. The company has a quick ratio of 9.10, a current ratio of 12.80 and a debt-to-equity ratio of 0.01. Canopy Growth has a 52-week low of $7.50 and a 52-week high of $56.60. The firm has a market capitalization of $11.37 billion, a price-to-earnings ratio of -161.03 and a beta of 3.14.

Canopy Growth (NYSE:CGC) last released its earnings results on Wednesday, June 27th. The marijuana producer reported ($0.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.23). The firm had revenue of $22.80 million for the quarter, compared to the consensus estimate of $24.19 million. Canopy Growth had a negative return on equity of 14.86% and a negative net margin of 159.94%. The business’s quarterly revenue was up 55.1% compared to the same quarter last year. equities research analysts forecast that Canopy Growth will post -0.37 earnings per share for the current year.

Several equities analysts have issued reports on CGC shares. Canaccord Genuity upgraded Canopy Growth from a “hold” rating to a “buy” rating in a research report on Thursday, August 16th. Zacks Investment Research downgraded Canopy Growth from a “hold” rating to a “sell” rating in a research report on Tuesday, August 28th.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.

Featured Story: Asset Allocation Models, Which is Right For You?

Insider Buying and Selling by Quarter for Canopy Growth (NYSE:CGC)

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with's FREE daily email newsletter.